Systematic analysis of the biological roles and pharmacological properties of D-chiro-inositol
D-chiroinositol (DCI) is one of the 9 inositol isomers that forms inositol phosphoglycans, which are mediators of the action of insulin. The metabolism of DCI and myo-inositol (MI) is impaired against the background of insulin resistance, including the patients with polycystic ovary syndrome (PCOS)....
Main Authors: | Olga A. Gromova, Ivan Yu. Torshin, Elena V. Uvarova, Natalya I. Tapilskaya, Alla G. Kalacheva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2020-07-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/34975/pdf |
Similar Items
-
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
by: Tatiana A. Oboskalova, et al.
Published: (2020-12-01) -
Efficiency of the D-chiro-inositol for the polycystic ovary syndrome
by: Т. Л. Архипкина, et al.
Published: (2019-04-01) -
A comparative study of combination of Myo-inositol and D-chiro-inositol versus Metformin in the management of polycystic ovary syndrome in obese women with infertility
by: Sujana Thalamati
Published: (2020-12-01) -
Differential Gene Expression and Biological Analyses of Primary Hepatocytes Following D-Chiro-Inositol Supplement
by: Feier Cheng, et al.
Published: (2021-07-01) -
PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol
by: Giovanni Monastra, et al.
Published: (2021-04-01)